Hoʻouna ʻia i ka lāʻau lapaʻau no ka maʻi maʻi maʻi

Hoʻouna ʻia i ka lāʻau lapaʻau no ka maʻi maʻi maʻi ka manaʻo e hoʻomaikaʻi i ka maikaʻi o ka mālama ʻana a hōʻemi i nā hopena ʻaoʻao ma o ka hāʻawi ʻana i nā mea lapaʻau kūikawā i nā maʻi maʻi maʻi, ʻoiai e hōʻemi ana i ka ʻike ʻana i nā ʻiʻo olakino. Ke hoʻohana nei kēia ala i nā hoʻolālā like ʻole, me nā nanoparticles, antibodies, a me nā peptides, e koho koho i nā maʻi maʻi maʻi a hoʻokuʻu i nā lāʻau lapaʻau ma ka pūnaewele tumor. Hoʻonui kēia hāʻawi ʻana i ka lāʻau i loko o ka ʻōpū, e alakaʻi ana i nā hopena i hoʻomaikaʻi ʻia a hōʻemi i ka ʻona ʻōnaehana. Hoʻouna ʻia i ka lāʻau lapaʻau no ka maʻi maʻi maʻi. ʻO ka pahuhopu mua o Hoʻouna ʻia i ka lāʻau lapaʻau no ka maʻi maʻi maʻi ʻo ka hoʻonui ʻana i ka hopena therapeutic o nā lāʻau lapaʻau ʻoiai e hōʻemi ana i kā lākou hopena ʻino i nā cell olakino. Loaʻa kēia ma ka hāʻawi pololei ʻana i nā lāʻau lapaʻau i ka pūnaewele tumor a i ʻole nā ​​​​pūnaewele maʻi kanesa, e hōʻoia ana i ka hopena o ka lāʻau lapaʻau ma kahi e pono ai. Ma ka Shandong Baofa Cancer Research Institute, ua hoʻolaʻa mākou i ka holomua ʻana i kēia kahua ma o ka noiʻi hou ʻana a me nā noi lapaʻau. Hiki i kēia ke alakaʻi i nā hopena koʻikoʻi, e like me ka nalowale o ka lauoho, nausea, a me ka hoʻopau ʻana i ka ʻōnaehana pale, no ka mea, ua hoʻopilikia pū ʻia nā cell olakino e nā lāʻau lapaʻau chemotherapy. Hoʻouna ʻia i ka lāʻau lapaʻau no ka maʻi maʻi maʻi hāʻawi i kekahi mau pōmaikaʻi nui: Nā hopena ʻaoʻao i hōʻemi ʻia: Ma ka huli pono ʻana i nā maʻi maʻi maʻi, mālama ʻia nā cell olakino, e alakaʻi ana i nā hopena ʻaoʻao liʻiliʻi a liʻiliʻi. Hoʻomaikaʻi maikaʻi ʻia: Hiki ke hāʻawi pololei ʻia nā kiʻekiʻe kiʻekiʻe o ka lāʻau lapaʻau i ka pūnaewele tumor, e hoʻonui ai i kona pono. Hoʻonui ʻia nā hopena maʻi: ʻOi aku ka maikaʻi a me ka hōʻemi ʻana i nā hopena ʻaoʻao hiki ke alakaʻi i ka maikaʻi o ke ola a me nā helu ola holoʻokoʻa no nā maʻi maʻi maʻi. Ke lanakila 'ana i ka lā'au kū'ē: Hiki ke kōkua i ka hāʻawi ʻana i ka lāʻau i ka pale ʻana i nā ʻano hana kūʻē i ka lāʻau e ulu ai nā maʻi maʻi maʻi i ka manawa. Hoʻouna ʻia i ka lāʻau lapaʻau no ka maʻi maʻi maʻi, kēlā me kēia me kona ʻano hana kūikawā no ke koho ʻana i nā pūnaewele maʻi kanesa: Passive Targeting ʻO ka huli ʻana e hilinaʻi ʻia i nā hiʻohiʻona kūʻokoʻa o ka ʻiʻo tumo, e like me nā kīʻaha koko leaky a me ka hoʻoheheʻe lymphatic impaired. Hoʻolālā ʻia nā nanoparticles e hoʻohana i kēia mau hiʻohiʻona, e hōʻiliʻili maikaʻi i ka microenvironment tumor. Ua kapa ʻia kēia ʻo ka Enhanced Permeability and Retention (EPR). Hoʻomaʻamaʻa kēia pilina i ka lawe ʻana i ka mea lawe lāʻau e nā maʻi kanesa. Aia kēia ʻano: Antibody-Drug Conjugates (ADCs) Aia nā ADC i kahi antibody e ʻike pono i kahi antigen pili i ka maʻi tumora, i hoʻopili ʻia i kahi lāʻau cytotoxic ikaika. Ke hoʻopaʻa ʻia ka ADC i ka cell cancer, hoʻokomo ʻia i loko, a hoʻokuʻu ʻia ka lāʻau lapaʻau i loko o ke kelepona, e alakaʻi ana i ka make cell. ʻO kahi laʻana ʻo Ado-Trastuzumab Emtansine (Kadcyla) e kuhikuhi ana i ka HER2-positive breast cancer cells [1].Ligand-Receptor InteractionsCancer cell often overexpress some receptors on their surface. Ma ka hoʻopili ʻana i nā ligand (nā molekole e hoʻopaʻa i kēia mau mea hoʻokipa) i nā mea lawe lāʻau, hiki ke hoʻopaʻa pololei ʻia ka lāʻau i kēia mau maʻi kanesa. ʻO ka folate receptors a me ka transferrin receptors he mau pahuhopu maʻamau [2] .Stimuli-Responsive DeliveryStimuli-responsive delivery system ua hoʻolālāʻia e hoʻokuʻu i nā lāʻau lapaʻau wale nō ke hoʻouluʻia e nā mea hoʻoikaika kiko'ī i loko o ka microenvironment tumor, e like me nā hoʻololi pH, ka hana enzyme, a iʻole ka hiki ke redox. Mālama kēia i ka hoʻokuʻu ʻia ʻana o ka lāʻau lapaʻau ma ka pūnaewele tumor wale nō, e hōʻemi ana i nā hopena o waho. ʻO nā laʻana e pili ana i ka hoʻohana ʻana i nā liposomes pH-sensitive e hoʻokuʻu i kā lākou uku i loko o ke kaiapuni ʻakika o nā ʻōpū [3].Nanoparticles in Targeted Drug DeliveryNanoparticles play a crucially role in Hoʻouna ʻia i ka lāʻau lapaʻau no ka maʻi maʻi maʻi. ʻO kēia mau ʻāpana liʻiliʻi, maʻamau mai ka 1 a 100 nanometer ka nui, hiki ke hana ʻia no ka lawe ʻana i nā lāʻau lapaʻau a hāʻawi koho iā lākou i nā maʻi maʻi maʻi. Hoʻohana ʻia nā ʻano nanoparticles, kēlā me kēia me kona pono ponoʻī: Liposome: Hiki i nā liposomes ke hoʻopili i nā lāʻau hydrophilic a me nā hydrophobic. Nā Nanoparticles Polymeric: Hana ʻia mai nā polymers biodegradable, hāʻawi kēia mau nanoparticles i ka hoʻokuʻu ʻana i ka lāʻau i hoʻomalu ʻia a hoʻonui i ka paʻa. Nā kiko kuantum: ʻO nā nanocrystals Semiconductor me nā waiwai optical kūʻokoʻa, hiki ke hoʻohana ʻia nā kiko quantum no ke kiʻi a me ka lawe ʻana i ka lāʻau. ʻO Carbon Nanotubes: Hiki ke hoʻohana ʻia nā ʻano cylindrical me nā ʻātoma kalapona, hiki ke hoʻohana ʻia nā nanotubes kalapona me nā ligands a me nā lāʻau lapaʻau. Hoʻouna ʻia i ka lāʻau lapaʻau no ka maʻi maʻi maʻi Aia nā ʻōnaehana i kēia manawa i ka hoʻohana lāʻau lapaʻau a i ʻole ke kūkulu ʻia nei: Doxil/Caelyx: ʻO Liposomal doxorubicin, i ʻae ʻia no ka mālama ʻana i ka maʻi maʻi ovarian, Kaposi's sarcoma, a me ka myeloma lehulehu [4]. ʻO kāna hana liposomal e hōʻemi i ka cardiotoxicity i hoʻohālikelike ʻia me ka doxorubicin kuʻuna. Abraxane: ʻO ka paclitaxel paʻa ʻo Albumin, hoʻohana ʻia no ka mālama ʻana i ka maʻi kanesa o ka umauma, ka maʻi maʻi ʻaʻai liʻiliʻi liʻiliʻi, a me ka maʻi maʻi pancreatic [5]. Hoʻonui ka hoʻopaʻa ʻana i ka albumin i ka lawe ʻana i ka lāʻau lapaʻau i ka pūnaewele tumor.Challenges and Future DirectionsWhile Hoʻouna ʻia i ka lāʻau lapaʻau no ka maʻi maʻi maʻi paʻa i ka ʻōlelo hoʻohiki nui, aia kekahi mau pilikia: Tumor Heterogeneity: Hiki ke hōʻike ʻia nā ʻano ʻano like ʻole o nā maʻi maʻi maʻi maʻi i loko o kahi ʻōpū, e paʻakikī ke hoʻopaʻa pono i nā cell āpau. Kūʻē Laʻau: Hiki i nā maʻi maʻi ke hoʻoikaika i ke kū'ē i nā lāʻau lapaʻau i hoʻopaʻa ʻia i ka manawa. ʻO nā pale hoʻouna: He mea paʻakikī paha ka hiki ʻana i ka wahi maʻi ma muli o nā pale physiological, e like me ka pale koko-lolo. Hoʻonui a me ka hana ʻana: ʻO ka hana ʻana i nā ʻōnaehana hoʻopuka lāʻau i manaʻo ʻia ma ke ʻano nui hiki ke paʻakikī a me ke kumu kūʻai. Hoʻohui i nā lāʻau lapaʻau i manaʻo ʻia me nā ʻano lapaʻau ʻē aʻe, e like me ka immunotherapy. Ke hana nei i nā ʻōnaehana hāʻawi stimuli-responsive i hiki ke hoʻololi i ka loli microenvironment tumor. Ka hoʻomaikaʻi ʻana i ka scalability a me ke kumu kūʻai o ka hana ʻana i nā ʻōnaehana hoʻopuka lāʻau lapaʻau. ʻO ke kuleana o Shandong Baofa Cancer Research InstituteAt Shandong Baofa Cancer Research Institute, ke komo ikaika nei mākou i ka noiʻi a me ka hoʻomohala ʻana i ka moʻolelo Hoʻouna ʻia i ka lāʻau lapaʻau no ka maʻi maʻi maʻi ʻōnaehana. Ke hana nei kā mākou hui ʻepekema a me nā kauka e lanakila i nā pilikia i ʻōlelo ʻia ma luna a unuhi i nā ʻike noiʻi hoʻohiki i loko o nā noi lapaʻau. Manaʻo mākou i kēlā Hoʻouna ʻia i ka lāʻau lapaʻau no ka maʻi maʻi maʻi he papahana koʻikoʻi no ka hoʻomaikaʻi ʻana i nā hopena lapaʻau maʻi maʻi a me ka hoʻomaikaʻi ʻana i ka maikaʻi o ke ola no nā maʻi maʻi maʻiHoʻouna ʻia i ka lāʻau lapaʻau no ka maʻi maʻi maʻi He holomua koʻikoʻi i ka mālama ʻana i ka maʻi kanesa, e hāʻawi ana i ka hiki ke hoʻomaikaʻi i ka pono a hōʻemi i nā hopena ʻaoʻao. Ma ke koho koho ʻana i nā cell cancer, hiki i kēia mau ʻōnaehana ke hāʻawi i nā kiʻekiʻe kiʻekiʻe o nā lāʻau lapaʻau pololei i ka pūnaewele tumora, e alakaʻi ana i nā hopena maikaʻi aʻe no nā maʻi. ʻOiai e mau ana nā pilikia, ke hoʻomau nei ka noiʻi a me ka hoʻomohala ʻana i ke ala no nā lāʻau lapaʻau maʻi maʻi ʻoi aku ka maikaʻi a pilikino. National Cancer Institute - Nā Hoʻohui Laʻau Antibody ʻO ka huli ʻana i ka folate receptor no ka maʻi kanesa pH-sensitive liposomes no ka maʻi kanesa. Keʻena Lapaʻau ʻEulopa - Doxil FDA - Abraxane Prescribing Information